fluorodeoxyglucose f18 has been researched along with Cancer of Mouth in 172 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (4.07) | 18.2507 |
| 2000's | 52 (30.23) | 29.6817 |
| 2010's | 85 (49.42) | 24.3611 |
| 2020's | 28 (16.28) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, MM; Baker, A; Fagiry, R; Ibrahim, N; Mahmood, S; Mair, M; Menon, I; Vaidhyanath, R | 1 |
| Cheng, NM; Fan, KH; Fang, KH; Fang, TJ; Hsieh, CH; Hsin, LJ; Hsueh, C; Huang, SF; Kang, CJ; Lee, LA; Lee, LY; Liao, CT; Lin, CH; Lin, CY; Lin, WN; Ng, SH; Tsai, CY; Tsao, CK; Wang, HM; Wang, YC; Yeh, CH; Yen, TC | 1 |
| Chen, YH; Cheng, SC; Guenette, J; Gunasti, L; Haddad, R; Jacene, HA; Jo, VY; Lako, A; Rodig, S; Schoenfeld, JD; Shah, H; Uppaluri, R; Wang, Y | 1 |
| Hirosue, A; Kawahara, K; Kitajima, M; Minamitake, A; Murakami, R; Nakayama, H; Sakamoto, F; Sakata, J; Shiraishi, S; Yamana, K; Yoshida, R | 1 |
| Gu, H; Li, M; Wang, Y; Wu, J; Xuan, G | 1 |
| Hyayashi, T; Nikkuni, Y; Nishiyama, H | 1 |
| Burian, E; Callahan, N; Froelich, MF; Gassert, FG; Makowski, MR; Palla, B; Pyka, T; Rübenthaler, J; Schmid, A; von Schacky, CE; Wolff, C | 1 |
| Chen, MYC; Hsu, JT; Lin, NC; Tsai, KY | 1 |
| Danstrup, CS; Fisker, R; Kovacsne, A; Lyhne, NM; Zacho, HD | 1 |
| Feng, J; Gao, X; He, Y; Hu, Y; Ma, Y; Pan, Y; Peng, L; Xu, F; Zhu, X | 1 |
| Kirita, T; Nakayama, Y; Tamaki, S; Ueda, N; Yagyuu, T; Yamakawa, N | 1 |
| Boyle, JO; Chen, L; Cohen, MA; Cracchiolo, JR; Dunn, L; Ganly, I; Gelblum, DY; Kang, JJ; Lee, NY; McBride, SM; Michel, LS; Patel, SG; Pfister, DG; Riaz, N; Schöder, H; Sherman, EJ; Singh, B; Tsai, CJ; Wong, RJ; Yu, Y; Zakeri, K | 1 |
| Calais, J; Czernin, J; Hotta, M; Howard, T; Maliha, PG; Mendelsohn, AH | 1 |
| Kuribayashi, A; Miura, M; Nakamura, S; Wamasing, N; Watanabe, H | 1 |
| Duvernay, J; Majoufre, C; Schlund, M | 1 |
| Shahid, A; Younis, MN | 1 |
| De Felice, F; Tombolini, V | 1 |
| Liu, Y | 1 |
| Harada, H; Hirai, H; Kugimoto, T; Kurabayashi, T; Kuroshima, T; Mochizuki, Y; Nakamura, S; Ohsako, T; Shimamoto, H; Tomioka, H; Tsushima, F | 1 |
| Fei, J; Guo, C; Niu, L; Wang, D; Zhang, J; Zheng, D | 1 |
| Arioka, T; Fukuhara, R; Fukuma, S; Hiraki, T; Kaji, M; Kanazawa, S; Marunaka, H; Masaoka, Y; Ogawa, N; Shinya, T; Tanaka, T | 1 |
| Andreu-Arasa, VC; Fujima, N; Meibom, SK; Mercier, GA; Sakai, O; Salama, AR; Truong, MT | 2 |
| Ishibashi, K; Kato, I; Kimura, M; Nagao, T; Sone, Y; Umemura, M | 1 |
| de Almeida, JR; Ferris, RL; Forner, D; Goldstein, DP; Metser, U; Noel, CW; Waldron, J | 1 |
| Bley, TA; Brands, RC; Brumberg, J; Buck, AK; Dierks, A; Hartmann, S; Haug, L; Herterich, T; Kertels, O; Kübler, AC; Lapa, C; Linz, C; Müller-Richter, U | 1 |
| Marcus, C; Subramaniam, RM | 1 |
| Kojima, I; Kouketsu, A; Kumamoto, H; Miyashita, H; Mori, S; Murata, T; Nagai, H; Nogami, S; Sakamoto, M; Takahashi, T; Yamauchi, K | 1 |
| Chen, MYC; Hsu, JT; Lin, NC; Su, IH; Tsai, KY | 1 |
| Ehrenfeld, M; Müller-Lisse, U; Obermeier, K; Otto, S; Probst, FA; Probst, M; Rominger, A; Troeltzsch, M | 1 |
| Asaka, T; Hirata, K; Kitagawa, Y; Kuge, Y; Ohga, N; Okamoto, S; Sato, J; Shiga, T; Shindoh, M; Tamaki, N; Watanabe, S | 1 |
| Bukawa, H; Hasegawa, S; Ishibashi-Kanno, N; Uchida, F; Yamagata, K; Yanagawa, T | 1 |
| Cipriani, NA; Ginat, DT; Uraizee, I | 1 |
| Li, C; Li, M; Li, Y; Xu, P; Yang, S | 1 |
| Asaka, T; Hirata, K; Kitagawa, Y; Ohga, N; Sato, J; Satoh, A; Shiga, T; Tamaki, N; Watanabe, S | 1 |
| Antonucci, MU; Day, TA; Hansen, RM | 1 |
| Asai, S; Fujioka, T; Harada, H; Michi, Y; Nakamura, S; Tateishi, U; Toriihara, A; Yamaga, E; Yoshimura, R | 1 |
| Choi, JW; Han, M; Kim, SY; Lee, D; Lee, SJ | 1 |
| Pal, R; Qiu, S; Vargas, G; Villarreal, P | 1 |
| de Bree, R; de Keizer, B | 1 |
| Creytens, D; Duprez, F; Goethals, I; Tomassen, P; Van Damme, A | 1 |
| Andriana, P; Higuchi, T; Hirasawa, H; Kim, M; Kurihara, J; Nakajima, T; Tokue, A; Tsushima, Y; Yokoo, S | 1 |
| Dong, Z; Fei, J; Gong, L; Li, K; Liu, W; Niu, L; Yan, R; Zheng, C; Zheng, D | 1 |
| Harada, H; Hayashi, K; Hino, M; Imai, Y; Ito, K; Kikuchi, M; Shimizu, K; Shinohara, S; Yamashita, D | 1 |
| Fukumura, M; Ishibashi, K; Kato, I; Kimura, M; Nagao, T; Nishiwaki, S; Shibata, A; Sone, Y; Umemura, M | 1 |
| Bellefqih, S; Dejust, S; El Farsaoui, K; Lalire, P; Morland, D | 1 |
| Asai, S; Fujikura, M; Kurabayashi, T; Nakamura, S | 1 |
| Achmad, A; Arisaka, Y; Higuchi, T; Kim, M; Miyashita, G; Miyazaki, H; Negishi, A; Tokue, A; Tominaga, H; Tsushima, Y; Yokoo, S | 1 |
| Habu, M; Kaneuji, T; Kitamura, C; Kito, S; Kodama, M; Koga, H; Kokuryo, S; Matsumoto-Takeda, S; Matsuo, K; Miyamoto, I; Morimoto, Y; Nishino, T; Nogami, S; Oda, M; Seta, Y; Tanaka, T; Tominaga, K; Wakasugi-Sato, N; Yamamoto, N; Yamashita, Y; Yoshiga, D; Yoshioka, I; Zhang, M | 1 |
| Kraft, SL; LaRue, SM; Randall, EK; Yoshikawa, H | 1 |
| Higuchi, T; Kaira, K; Kanai, Y; Kim, M; Miyashita, G; Negishi, A; Nobusawa, A; Oriuchi, N; Oyama, T; Tsushima, Y; Yokoo, S | 1 |
| Zafereo, ME | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 1 |
| Chang, CY; Lin, KH; Liu, RS; Shih, WJ; Wang, SJ; Yang, BH | 1 |
| Afify, AM; Farwell, DG; Ferrara, KW; Haynam, EM; Mahakian, LM; Poirier, B; Seo, JW; Shaye, D; Tinling, SP; Zhang, H | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Nam, SY; Roh, JL; Ryu, IS | 1 |
| Ho, TY; Lee, LY; Liao, CT; Lin, CY; Tseng, JR; Wang, HM; Yen, TC | 1 |
| Asaka, T; Hata, H; Kitagawa, Y; Kuge, Y; Miyakoshi, M; Okamoto, S; Sato, J; Shiga, T; Shindoh, M; Tamaki, N; Yamazaki, Y | 1 |
| Arya, S; Deshmukh, A; Rane, P | 1 |
| Hasegawa, M; Imai, Y; Kirita, T; Kuniyasu, H; Kurihara, M; Sasahira, T; Shimomura, H; Shirone, N; Tamaki, S; Yamakawa, N; Yamanaka, Y | 1 |
| An, YS; Jo, KS; Kim, CH; Kwon, SH; Lee, DH; Lee, SJ; Shin, YS; Yoon, JK | 1 |
| Cho, KJ; Choi, SH; Hong, HR; Jin, S; Kim, JS; Kim, SY; Koo, HJ; Nam, SY; Roh, JL | 1 |
| Abele, JT; Harris, JR; Jeffery, DT; O'Connell, DA; Seikaly, H; Zhang, H | 1 |
| Achmad, A; Arisaka, Y; Higuchi, T; Kim, M; Tsushima, Y; Yokoo, H; Yokoo, S | 1 |
| Brandau, S; Franklin, C; Hermann, S; Jure-Kunkel, M; Kerem, A; Lang, S; Öztürk, E; Schäfers, M; Vahle, AK; Wildner, M | 1 |
| Chang, KP; Fan, KH; Fang, KH; Ho, TY; Huang, SF; Kang, CJ; Lee, LY; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yang, LY; Yen, TC | 1 |
| Jeon, TY; Kim, HJ; Kim, YW; Lee, BJ; Lee, JC | 1 |
| Beitler, JJ; Corey, A; El-Deiry, MW; Galt, J; Higgins, K; Hudgins, PA; Kendi, AT; Magliocca, K; Nickleach, DC; Saba, NF; Schuster, DM; Wadsworth, JT | 1 |
| Agrawal, A; Jatale, P; Purandare, NC; Puranik, AD; Rangarajan, V; Sawant, S; Shah, S | 1 |
| Bluemel, C; Kircher, S; Lapa, C; Linz, C; Müller-Richter, UD | 1 |
| Corey, A; El-Deiry, MW; Galt, J; Hudgins, PA; Kendi, AT; Magliocca, KR; Nickleach, DC; Saba, NF; Schuster, DM; Switchenko, JM; Wadsworth, JT | 1 |
| Carlson, ER; Heidel, RE; Schaefferkoetter, JD | 1 |
| Burger, IA; Haerle, SK; Huber, GF; Hüllner, M; Müller, J; Strobel, K | 1 |
| Fakhry, C; Kang, H; Kiess, AP; Marcus, C; Pasha, MA; Subramaniam, RM | 1 |
| Gu, T; Jiang, L; Liu, F; Luan, L; Shi, H | 1 |
| Hirota, M; Inoue, T; Iwai, T; Kioi, M; Koike, I; Koizumi, T; Mitsudo, K; Oguri, S; Shimizu, M; Taguri, M; Tohnai, I | 1 |
| Habu, M; Kito, S; Kodama, M; Koga, H; Kokuryo, S; Matsumoto-Takeda, S; Matsuo, K; Miyamoto, I; Morimoto, Y; Nishimura, S; Nishino, T; Oda, M; Sasaguri, M; Tanaka, T; Tominaga, K; Uehara, M; Yoshiga, D; Yoshioka, I | 1 |
| Abele, JT; Dziegielewski, PT; Harris, JR; Nguyen, NT; O'Connell, DA; Seikaly, H; Zhang, H | 1 |
| Akin, O; Arslan, A; Deniz, E; Ozcakir-Tomruk, C | 1 |
| De Carvalho Bittencourt, M; Dolivet, G; Faure, GC; Mastronicola, R; Tu, Q; Wu, X | 1 |
| Blodgett, T; Carlson, E; Faul, D; Lemmens, C; Long, M; Nahmias, C; Nuyts, J; Townsend, D | 1 |
| Nakagawa, T; Suzuki, Y; Yamada, M | 1 |
| Baba, H; Kobayashi, S; Nakajima, H; Okazawa, H; Takamura, T; Tsuchida, T; Uchida, K | 1 |
| Baek, CH; Cho, JK; Choi, J; Choi, JY; Chung, MK; Jeong, HS; Kim, HJ; Ko, YH; Son, YI; Yim, YJ | 1 |
| Brusa, M; Carnino, R; Cistaro, A; Colombini, E; Ferraris, MM; Gandolfo, S; Giovanella, L; Pentenero, M; Pezzuto, C; Spriano, G; Valentini, MC | 1 |
| Hasegawa, Y; Hyodo, I; Nakashima, T; Nishio, M; Suzuki, H; Tamaki, T; Terada, A | 1 |
| Chang, JT; Chen, IH; Cheng, AJ; Hsueh, C; Huang, SF; Lee, LY; Liao, CT; Lin, CH; Ng, SH; See, LC; Wang, HM; Yen, TC | 1 |
| Chang, JT; Chen, IH; Cheng, AJ; Hsueh, C; Huang, SF; Lee, LY; Liao, CT; Lin, CH; Ng, SH; Wang, HM; Yen, TC | 2 |
| Bussink, J; Kaanders, JH; Oyen, WJ; Troost, EG | 1 |
| Fukuyama, R; Hasegawa, Y; Nakashima, T; Nishio, M; Suzuki, H; Tamaki, T; Tatematsu, M | 1 |
| Diener, J; Grünwald, F; Kovács, AF; Wallowy, P | 1 |
| Krabbe, CA; Pruim, J; Roodenburg, JL; van der Wal, JE; van der Werff-Regelink, G | 1 |
| Buchmann, I; Freier, K; Haberkorn, U; Hofele, C; Thiele, OC | 1 |
| Bisdas, S; Chambron-Pinho, N; Mack, M; Middendorp, M; Sader, R; Seitz, O; Vogl, TJ | 1 |
| Bold, B; Ishida, R; Okada, N; Omura, K; Piao, Y; Shibuya, H; Tayier, A | 1 |
| Balink, H; de Visscher, JG; Dijkstra, PU; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF | 1 |
| Agool, A; Brouwers, AH; Dijkstra, PU; Krabbe, CA; Phan, TT; Pruim, J; Roodenburg, JL; Scholtens, AM | 1 |
| Hijioka, H; Ikeda, R; Ishida, T; Miyawaki, A; Nakamura, N; Nozoe, E; Ushiyama, M | 1 |
| Chang, JT; Chen, IH; Cheng, AJ; Hsueh, C; Huang, SF; Lee, LY; Liao, CT; Lin, CH; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Fajnwak, P; Farghaly, HR; Nguyen, NC; Osman, MM | 1 |
| Arisaka, Y; Endo, K; Hanaoka, H; Higuchi, T; Ishikita, T; Miyakubo, M; Miyashita, G; Morita, S; Nakasone, Y; Negishi, A; Oriuchi, N; Tominaga, H; Yokoo, S | 1 |
| Al-Nahhas, A; Barwick, T; Howard, DJ; Patel, NH; Salem, S; Win, Z; Zerizer, I | 1 |
| Bae, SH; Chang, SK; Choi, CS; Gu, DH; Lim, KJ; Park, CH; Seo, YL; Yoon, DY; Yun, EJ | 1 |
| Ishikawa, A; Kito, S; Koga, H; Matsumoto-Takeda, S; Matsuo, K; Miyamoto, I; Morimoto, Y; Oda, M; Seta, Y; Shiiba, S; Takahashi, T; Tanaka, T; Wakasugi-Sato, N; Yamamoto, N; Yamashita, Y; Yamauchi, K | 1 |
| Kositwattanarerk, A | 1 |
| Balsamo, V; Ceraudo, F; Cistaro, A; Cusmà, S; Ficola, U; Gandolfo, S; Migliaretti, G; Palandri, S; Pentenero, M; Testa, C | 1 |
| Liao, CT; Liu, FY; Yen, TC | 1 |
| Fujibayashi, Y; Hata, H; Kitagawa, Y; Kotsuji, M; Nakamura, M; Okazawa, H; Sano, K; Yamazaki, Y; Yonekura, Y | 1 |
| Chang, CC; Chien, CY; Fang, FM; Huang, SH; Huang, YC; Hung, BT; Lin, WC; Lui, CC; Tu, MC; Wang, PW | 1 |
| Balink, H; de Visscher, JG; Dol, J; Krabbe, CA; Roodenburg, JL | 1 |
| Cheng, NM; Ho, KC; Hsueh, C; Liao, CT; Ng, SH; Yeh, TW; Yen, TC | 1 |
| Ciarallo, A; Lisbona, R; Makis, W | 1 |
| Ichikawa, K; Komatsu, N; Sato, E; Sugimoto, K; Sunami, Y; Ushimi, T; Watanabe, N | 1 |
| Chang, JT; Chen, IH; Chen, YJ; Cheng, AJ; Fan, KH; Huang, SF; Lee, LY; Li, YL; Liao, CT; Lin, CY; Lin, TY; Wang, HM | 1 |
| Chen, IH; Fan, KH; Hsueh, C; Huang, SF; Kang, CJ; Lee, LY; Liao, CT; Lin, CH; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Al Jammaz, I; Al-Hokbany, N; Al-Otaibi, B; Amer, S; Okarvi, S | 1 |
| Allen-Auerbach, M; Czernin, J; Karantanis, D | 1 |
| Abe, K; Chikui, T; Goto, Y; Hirano, M; Jinno, T; Kawano, S; Kiyosue, T; Matsubara, R; Nagata, T; Nakamura, S; Oobu, K | 1 |
| Alvarez, AC; Cook, EF; Dibble, EH; Mercier, G; Subramaniam, RM; Truong, MT | 1 |
| Harada, H; Kurabayashi, T; Mochizuki, Y; Nakamura, S; Omura, K; Shibuya, H | 1 |
| Chien, CY; Chuang, HC; Huang, HY; Huang, SH; Lin, WC | 1 |
| Kitamura, N; Kwang-Lee, K; Sasabe, E; Uchida, M; Yamada, T; Yamamoto, T; Yoshimura, T | 1 |
| Routray, S; Shankar, AA | 1 |
| Honda, E; Ishimaru, N; Kubo, M; Miyamoto, Y; Otsuka, H; Sugawara, C; Takahashi, A | 1 |
| Abd El-Hafez, YG; Khalil, HF; Liao, CT; Moustafa, HM; Yen, TC | 1 |
| Cho, KJ; Joo, YH; Kim, MS; Nam, IC; Park, JO; Yoo, IR | 1 |
| Bartel, T; Cool, S; Entine, G; Gaysinskiy, V; Lowe, V; Nagarkar, V; Singh, B; Stack, BC; Thacker, S | 1 |
| Chen, L; Ge, SY; Li, HQ; Zhou, HW | 1 |
| Bartenstein, P; Benz, P; Förster, GJ; Kunkel, M; Kutzner, J; Reichert, TE; Wagner, W | 1 |
| Bartenstein, P; Benz, P; Jeong, JH; Kunkel, M; Lehr, HA; Reichert, TE; Wagner, W; Whiteside, TL; Wieand, S | 1 |
| Ell, P; Hyde, NC; Newman, L; Prvulovich, E; Visvikis, D; Waddington, WA | 1 |
| Eyrich, GK; Goerres, GW; Grätz, KW; Schmid, DT; von Schulthess, GK | 1 |
| Endo, K; Mogi, K; Nakasone, Y; Tian, M; Zhang, H | 1 |
| Bartenstein, P; Benz, P; Förster, GJ; Jeong, JH; Kunkel, M; Reichert, TE; Wagner, W; Whiteside, TL | 1 |
| Bartenstein, P; Helisch, A; Kunkel, M; Reichert, TE; Wagner, W | 1 |
| Brouwer, J; Castelijns, JA; Comans, EF; de Bree, R; Hoekstra, OS; Leemans, CR | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sano, K; Yonekura, Y | 1 |
| Anzai, Y; Coltrera, MD; Eary, J; Ford, EC; Haynor, D; Kinahan, P; Krohn, K; Laramore, GE; Leblanc, M; Lewellen, B; Mattes, D; Meyer, J; Phillips, M; Rajendran, J; Schwartz, DL; Virgin, J; Yueh, B | 1 |
| Bares, R; Claussen, C; Claussen, CD; Dammann, F; Eschmann, S; Hoffman, J; Horger, M; Mueller-Berg, M; Schlemmer, H | 1 |
| Chan, SC; Chang, JT; Chang, YC; Chen, TM; Kang, CJ; Liao, CT; Lin, KJ; Ng, SH; See, LC; Wang, HM; Wu, YF; Yen, TC | 1 |
| Chan, SC; Chang, JT; Ko, SF; Liao, CT; Ng, SH; Wang, HM; Wong, HF; Yen, TC | 1 |
| Krabbe, PF; Oyen, WJ; van Dalen, JA; van den Hoogen, FJ; Vogel, WV; Wensing, BM | 1 |
| Endo, K; Higuchi, T; Mogi, K; Nakajima, N; Nakasone, Y; Oriuchi, N; Takata, K; Tian, M; Zhang, H | 1 |
| Eyrich, GK; Goerres, GW; Schmid, DT; Schuknecht, B | 1 |
| Bartenstein, P; Benz, P; Buchholz, HG; Helisch, A; Jeong, JH; Kunkel, M; Reichert, TE; Wagner, W; Whiteside, TL | 1 |
| Biswal, S; Do, B; Gambhir, SS; Kalinyak, J; Mari, C; Quon, A | 1 |
| Carlson, DL; Erdi, YE; Gönen, M; Huvos, AG; Kraus, DH; Larson, SM; Schöder, H; Shah, JP; Stambuk, HE; Wong, RJ; Yeung, HW | 1 |
| Marres, HA; Merkx, MA; Oyen, WJ; Postema, EJ; van den Hoogen, FJ; Vogel, WV; Wensing, BM | 1 |
| Waldron, JN | 1 |
| Chan, SC; Chang, JT; Kang, CJ; Ko, SF; Lee, LY; Liao, CT; Ng, SH; Wang, HM; Wong, AM; Yen, TC | 1 |
| Döbert, N; Kovács, AF; Landes, CA; Walendzik, H; Zaplatnikov, K | 1 |
| Lin, EC | 1 |
| Dijkstra, PU; Gravendeel, JP; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF; van der Wal, JE | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Ryu, CH | 1 |
| Bybel, B | 1 |
| Bilodeau, PA; Coleman, TA; Gourin, CG; Patel, VS; Watts, TL; Williams, HT | 1 |
| Boering, G; Braams, JW; Freling, NJ; Nikkels, PG; Pruim, J; Roodenburg, JL; Vaalburg, W; Vermey, A | 1 |
| Bailet, J; Chaiken, L; Choi, Y; Hanafee, WN; Hoh, CK; Jabour, BA; Lufkin, RB; Maddahi, J; Rege, SD; Soong, JC | 1 |
| Anzai, Y; Bradford, CR; Carroll, WR; Minoshima, S; Quint, DJ; Wahl, RL; Wolf, GT | 1 |
| Braams, JW; Nikkels, PG; Nooren, CA; Roodenburg, JL; Vaalburg, W; Vermey, A; Witjes, MJ | 1 |
| AAssar, OS; Caputo, GR; Dillon, WP; Fischbein, NJ; Hawkins, RA; Kaplan, MJ; Price, DC; Singer, MI | 1 |
| Benz, P; Grötz, KA; Kuffner, HD; Kunkel, M; Spitz, J; Wagner, W; Wahlmann, U | 1 |
| Myers, LL; Wax, MK | 1 |
| Akhurst, T; Berlangieri, SU; Feigen, M; Hannah, A; McKay, WJ; Quong, G; Scott, AM; Zalcberg, J; Zimet, A | 1 |
| Benz, P; Förster, GJ; Kuffner, HD; Kunkel, M; Reichert, TE; Wagner, W | 1 |
| Benz, P; Förster, GJ; Grötz, KA; Kunkel, M; Kutzner, J; Rippins, G; Wagner, W; Wahlmann, U | 1 |
| Adams, S; Baum, RP; Kovács, AF; Stuckensen, T | 1 |
| Endo, K; Inoue, T; Mogi, K; Nakasone, Y; Negishi, A; Oriuchi, N; Takeuchi, K | 1 |
| Kitagawa, Y; Maruta, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Grüterich, G; Kovács, AF; Wagner, M | 1 |
| Pfaltz, M; Schmid, S; Steinert, H; Stoeckli, SJ | 1 |
3 review(s) available for fluorodeoxyglucose f18 and Cancer of Mouth
| Article | Year |
|---|---|
Diagnostic efficacy of combined CT and MRI in detecting nodal metastasis in patients with oral cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mouth Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
Evaluation and staging of squamous cell carcinoma of the oral cavity and oropharynx: limitations despite technological breakthroughs.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Sentinel Lymph Node Biopsy | 2013 |
FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mouth Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Squamous Cell; Patient Care Planning; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2015 |
15 trial(s) available for fluorodeoxyglucose f18 and Cancer of Mouth
| Article | Year |
|---|---|
Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
Topics: Carcinoma, Squamous Cell; Epithelial Cells; Fluorodeoxyglucose F18; Glucose; Head and Neck Neoplasms; Humans; Immunotherapy; Mouth Neoplasms; Nivolumab; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Mouth; Mouth Neoplasms; Multivariate Analysis; Neck; Patient Selection; Positron-Emission Tomography; Preoperative Period; Prognosis; Recurrence; Risk Factors; Salvage Therapy; Survival Analysis; Time Factors | 2009 |
Detection of cervical metastases with (11)C-tyrosine PET in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with (18)F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tyrosine | 2010 |
18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Recurrence; Time Factors | 2009 |
¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prospective Studies; Tyrosine | 2010 |
Assessment of a new 18F-FDG PET/CT protocol in the staging of oral cavity carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2011 |
Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread.
Topics: Adult; Aged; Chemoradiotherapy; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm, Residual; Positron-Emission Tomography; Radiotherapy, Adjuvant; Recurrence; Risk; Survival Analysis | 2012 |
Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.
Topics: Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 2; Humans; Male; Middle Aged; Monosaccharide Transport Proteins; Mouth Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, Emission-Computed | 2004 |
Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2003 |
FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2005 |
Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
Topics: Adult; Carcinoma, Squamous Cell; Case-Control Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Hexokinase; Humans; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2005 |
18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
154 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Mouth
| Article | Year |
|---|---|
Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastases.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Node Ratio; Lymph Nodes; Mouth Neoplasms; Neoplasm Staging; Prognosis; Retrospective Studies | 2021 |
Laterality on FDG-PET/CT in clinically node-negative early-stage oral squamous cell carcinoma: a retrospective analysis of patients with late neck metastasis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2022 |
Survival benefit associated with postoperative PET-CT before adjuvant radiotherapy or chemoradiotherapy in patients with oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2022 |
Histogram analysis of
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2022 |
Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
Topics: Carcinoma, Squamous Cell; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Mouth Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2022 |
Maximum standardised uptake value is prognostic in patients with early-stage squamous cell carcinoma of the tongue.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tongue | 2022 |
Frequency and malignancy rate of incidental focal salivary gland lesions identified by 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Mouth Neoplasms; Parotid Gland; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
A prediction model of nodal metastasis in cN0 oral squamous cell carcinoma using metabolic and pathological variables.
Topics: Carcinoma, Squamous Cell; China; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Volume-based 18F-fluorodeoxyglucose positron emission tomography/computed tomography parameters correlate with delayed neck metastasis in clinical early-stage oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines; Sialadenitis; Squamous Cell Carcinoma of Head and Neck | 2023 |
Potential of preoperative fluorodeoxyglucose-positron emission tomography/computed tomography to diagnose contralateral lymph node metastases in patients with oral cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2023 |
Contribution of FDG-PET in the diagnostic assessment of cervical lymph node metastasis in Oral Cavity Squamous Cell Carcinoma (OCSCC).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Detection of Recurrence in Retromolar Trigone using "Puffed Cheek" F-18 FDG PET-CT Scan.
Topics: Cheek; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2019 |
[
Topics: Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Poly(ADP-ribose) Polymerases; Positron-Emission Tomography | 2019 |
Large Idiopathic Mesenteric Necrotizing Granuloma Mimicking Metastatic Disease on FDG PET/CT.
Topics: Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Granuloma; Humans; Male; Mouth Neoplasms; Necrosis; Peritoneal Neoplasms; Peritoneum; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2020 |
Detection of extraoral primary cancers by positron emission tomography/computed tomography in patients with oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2020 |
Accuracy of
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
The Diagnostic Capacity of Pre-treatment 18F-FDG PET/CT for Predicting the Extranodular Spread of Lymph Node Metastases in Patients with Oral Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Squamous Cell Carcinoma of Head and Neck | 2020 |
Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Deep Learning; Diagnosis, Computer-Assisted; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Burden | 2020 |
Texture Analysis Using Preoperative Positron Emission Tomography Images May Predict the Prognosis of Patients With Resectable Oral Squamous Cell Carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2021 |
Elective neck dissection versus positron emission tomography-computed tomography-guided management of the neck in clinically node-negative early oral cavity cancer: A cost-utility analysis.
Topics: Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Neck Dissection; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth; Mouth Neoplasms; Neck; Neck Dissection; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2021 |
Prediction of the treatment outcome using machine learning with FDG-PET image-based multiparametric approach in patients with oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Machine Learning; Male; Middle Aged; Mouth; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2021 |
Beyond the
Topics: Carcinoma, Squamous Cell; Electrons; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Squamous Cell Carcinoma of Head and Neck | 2022 |
Comparison of different diagnostic imaging techniques for the detection of bone invasion in oral cancers.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mandible; Mouth Neoplasms; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2021 |
FDG-PET predicts bone invasion and prognosis in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taiwan | 2021 |
Comorbidity Assessment in Patients With Oral Squamous Cell Carcinoma: Can Imaging Techniques (Fludeoxyglucose Positron-Emission Tomographic Computed Tomography and Contrast-Enhanced Computed tomography) Provide Additional Information?
Topics: Carcinoma, Squamous Cell; Comorbidity; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2018 |
Topics: Adult; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tumor Hypoxia | 2017 |
Usefulness of esophagogastroduodenoscopy and
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Early Detection of Cancer; Endoscopy, Digestive System; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2017 |
Adenoid Cystic Carcinoma of the Oral Cavity: Radiology-Pathology Correlation.
Topics: Carcinoma, Adenoid Cystic; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2018 |
Positron Emission Tomographic Imaging Elucidates the Complex Relationship Between Glucose Uptake and Tissue Blood Flow Mechanism in Squamous Cell Oral Cancer Patients.
Topics: Adult; Aged; Blood Flow Velocity; China; Epithelial Cells; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Squamous Cell; Positron-Emission Tomography; Retrospective Studies | 2017 |
Hypoxic volume evaluated by
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Neck Dissection; Neoplasm Grading; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Treatment Outcome; Tumor Hypoxia | 2018 |
Hypermetabolic Vocal Cord Focus With Recurrent Oral Cancer History.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Laryngitis; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Vocal Cords | 2018 |
Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2018 |
Correlation of human papilloma virus status with quantitative perfusion/diffusion/metabolic imaging parameters in the oral cavity and oropharyngeal squamous cell carcinoma: comparison of primary tumour sites and metastatic lymph nodes.
Topics: Aged; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Organometallic Compounds; Oropharyngeal Neoplasms; Papillomaviridae; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
In-vivo topical mucosal delivery of a fluorescent deoxy-glucose delineates neoplasia from normal in a preclinical model of oral epithelial neoplasia.
Topics: Animals; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Mouth Neoplasms; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography | 2018 |
Is there a place for FDG-PET-CT in early oral cancer patients?
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2018 |
Radiochemotherapy-induced reactivation of scar tissue on
Topics: Chemoradiotherapy; Cicatrix; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Positron Emission Tomography Computed Tomography | 2018 |
Topics: alpha-Methyltyrosine; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Positron-Emission Tomography; Prognosis | 2019 |
Correlation analysis between the SUVmax of FDG-PET/CT and clinicopathological characteristics in oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2019 |
Clinical Value of Fused PET/MRI for Surgical Planning in Patients With Oral/Oropharyngeal Carcinoma.
Topics: Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mandibular Neoplasms; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Invasiveness; Oropharyngeal Neoplasms; Patient Care Planning; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2020 |
The prognostic significance of intratumoral heterogeneity of 18F-FDG uptake in patients with oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2019 |
18F-FDG PET/CT in Oral Cuniculatum Carcinoma.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2019 |
Diagnostic ability of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography for retropharyngeal lymph node in patients with oral cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Pharynx; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Topics: Aged; Aged, 80 and over; Bone Marrow Neoplasms; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2013 |
Variety and complexity of fluorine-18-labelled fluoro-2-deoxy-D-glucose accumulations in the oral cavity of patients with oral cancers.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Facial Muscles; Female; Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Mandible; Maxilla; Middle Aged; Mouth; Mouth Neoplasms; Multimodal Imaging; Palatine Tonsil; Positron-Emission Tomography; Radiopharmaceuticals; Sublingual Gland; Tomography, X-Ray Computed; Tongue; Tongue Neoplasms; Young Adult | 2013 |
Evaluation of 18F-FDG PET/CT as a diagnostic imaging and staging tool for feline oral squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cat Diseases; Cats; Female; Fluorodeoxyglucose F18; Lymph Nodes; Male; Mouth Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Large Neutral Amino Acid-Transporter 1; Male; Methyltyrosines; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymph Nodes; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Multivariate Analysis; Neck; Pharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Young Adult | 2014 |
Feasibility and incremental benefit of puffed-cheek 18F-FDG PET/CT on oral cancer patients.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Cheek; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Comparison of PET imaging with 64Cu-liposomes and 18F-FDG in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch model of oral dysplasia and squamous cell carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Brain; Carcinoma, Squamous Cell; Copper Radioisotopes; Cricetinae; Disease Models, Animal; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heart; Liposomes; Mouth Neoplasms; Positron-Emission Tomography | 2014 |
Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Patient Outcome Assessment; Pharynx; Positron-Emission Tomography; Recurrence; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2013 |
Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Positron-Emission Tomography; Preoperative Period; Treatment Outcome | 2014 |
Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mouth Neoplasms; Multidetector Computed Tomography; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Tumor Burden | 2014 |
[18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals | 2015 |
Prognostic significance of the intratumoral heterogeneity of (18) F-FDG uptake in oral cavity cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed | 2014 |
Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Carcinoma, Squamous Cell; Contrast Media; Dental Implants; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Metabolic tumour volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Methyltyrosines; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti-CD137 tumor immune therapy.
Topics: 4-1BB Ligand; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Immunohistochemistry; Immunotherapy; Longitudinal Studies; Magnetic Resonance Imaging; Mice; Mice, Inbred C3H; Mouth Neoplasms; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Squamous Cell Carcinoma of Head and Neck | 2016 |
Positive clinical impact of an additional PET/CT scan before adjuvant radiotherapy or concurrent chemoradiotherapy in patients with advanced oral cavity squamous cell carcinoma.
Topics: Adult; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Solitary peritoneal lymph node metastasis of head and neck cancer diagnosed with FDG-PET/CT imaging.
Topics: Adult; Carcinoma, Squamous Cell; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Mouth Floor; Mouth Neoplasms; Multimodal Imaging; Peritoneum; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Oropharyngeal Neoplasms; Papillomaviridae; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Asymptomatic myocardial metastasis from cancers of upper aero-digestive tract detected on FDG PET/CT: a series of 4 cases.
Topics: Adult; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tongue Neoplasms | 2014 |
Value of FDG PET/CT in staging of oral cancer: four simultaneous primary malignancies.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
Topics: Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Mouth; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Proportional Hazards Models; Radiographic Image Enhancement; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Cell Proliferation; Cohort Studies; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Otorhinolaryngologic Surgical Procedures; Plastic Surgery Procedures; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Surgical Flaps; Tomography, X-Ray Computed | 2015 |
A Case of Oral Metastasis From Hepatocellular Carcinoma Displayed on 18F-FDG PET/CT Imaging.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Prognostic value of 2-[(18) F]fluoro-2-deoxy-D-glucose positron emission tomography for patients with oral squamous cell carcinoma treated with retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2016 |
Alterations in 18F-FDG accumulation into neck-related muscles after neck dissection for patients with oral cancers.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mouth Neoplasms; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Validation of metabolic tumor volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2016 |
A case report of metastasis of malignant mesothelioma to the retromolar trigone.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Calbindin 2; Cisplatin; Deoxycytidine; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Gemcitabine; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Mouth Neoplasms; Pemetrexed; Pleural Neoplasms; Positron Emission Tomography Computed Tomography; Radiography, Panoramic; Radiotherapy, Adjuvant | 2016 |
A rare case of extremely high counts of circulating tumor cells detected in a patient with an oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neoplastic Cells, Circulating; Positron Emission Tomography Computed Tomography; Recurrence | 2016 |
Does reducing CT artifacts from dental implants influence the PET interpretation in PET/CT studies of oral cancer and head and neck cancer?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Dental Implants; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2008 |
Neurological improvement associated with resolution of irradiation-induced myelopathy: serial magnetic resonance imaging and positron emission tomography findings.
Topics: Brown-Sequard Syndrome; Central Nervous System Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiation Injuries; Radiotherapy; Recovery of Function; Spinal Cord; Steroids | 2009 |
Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
Topics: Adult; Aged; Artifacts; Dental Implants; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2009 |
Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome | 2009 |
Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Survival Rate | 2009 |
18F-FDG and 18F-FLT do not discriminate between reactive and metastatic lymph nodes in oral cancer.
Topics: Dideoxynucleosides; Excitatory Amino Acid Transporter 2; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas.
Topics: Adult; Aged; beta Catenin; Cadherins; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Proto-Oncogene Proteins c-bcl-2; Radiopharmaceuticals; Survival Analysis; Vascular Endothelial Growth Factor A | 2009 |
18F-FDG PET for detecting metastases and synchronous primary malignancies in patients with oral and oropharyngeal cancer.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Oropharyngeal Neoplasms; Palatal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tongue Neoplasms | 2009 |
High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis | 2009 |
18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement.
Topics: Carboplatin; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Nuclear Medicine; Observer Variation; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Chemotherapy, Adjuvant; Cisplatin; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Inhibitory Concentration 50; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Vascular Endothelial Growth Factor A | 2010 |
Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Tomography, X-Ray Computed | 2010 |
18f-fdg pet for routine posttreatment surveillance in oral and oropharyngeal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Monitoring, Physiologic; Mouth Neoplasms; Oropharyngeal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results | 2010 |
Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neck.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Uvula | 2010 |
CT, MR, (18)F-FDG PET/CT, and their combined use for the assessment of mandibular invasion by squamous cell carcinomas of the oral cavity.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Iohexol; Magnetic Resonance Imaging; Male; Mandible; Mandibular Neoplasms; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Diagnostic significance of characteristic findings on ultrasonography for the stitch abscess after surgery in patients with oral squamous cell carcinoma.
Topics: Abscess; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Surgical Wound Infection; Sutures; Tomography, X-Ray Computed; Ultrasonography | 2011 |
PET/CT in oral cavity and oropharyngeal cancer in post therapy setting.
Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Synchronous malignancies in patients with squamous cell carcinomas of the oral cavity.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2011 |
Increased glucose metabolism by FDG-PET correlates with reduced tumor angiogenesis in oral squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Male; Middle Aged; Mouth Neoplasms; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric | 2012 |
A comparative study of fused FDG PET/MRI, PET/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Demography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
False positive F-18 FDG PET/CT in neck and mediastinum lymph nodes due to anthracosis in a buccal cancer patient.
Topics: Anthracosis; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Mediastinum; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neck; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: staging with 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
18F-Fluorodeoxyglucose positron emission tomography/computed tomography revealed the presence of simultaneous colon cancer in mucosa-associated lymphoid tissue lymphoma.
Topics: Aged; Blotting, Southern; Colonic Neoplasms; Colonoscopy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; In Situ Hybridization, Fluorescence; Lymphoma, B-Cell, Marginal Zone; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Male; Membrane Glycoproteins; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy | 2011 |
Novel synthesis and preclinical evaluation of folic acid derivatives labeled with (18)F-[FDG] for PET imaging of folate receptor-positive tumors.
Topics: Animals; Biological Transport; Chemistry Techniques, Synthetic; Drug Stability; Female; Fluorodeoxyglucose F18; Folic Acid; Folic Acid Transporters; Humans; Isotope Labeling; KB Cells; Methotrexate; Mice; Mouth Neoplasms; Positron-Emission Tomography | 2012 |
Squamous papilloma of the oral cavity and oropharynx on 18F-FDG PET/CT imaging.
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Male; Mouth; Mouth Neoplasms; Multimodal Imaging; Oropharynx; Papilloma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2012 |
18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Mouth Neoplasms; Multivariate Analysis; Neoplasm Staging; Neoplasms, Squamous Cell; Oropharyngeal Neoplasms; Prognosis; Proportional Hazards Models; Retrospective Studies; Tumor Burden | 2012 |
Preoperative predictive model of cervical lymph node metastasis combining fluorine-18 fluorodeoxyglucose positron-emission tomography/computerized tomography findings and clinical factors in patients with oral or oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anatomy, Regional; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2012 |
A pilot study of segmental mandibulectomy with surgical navigation using fluorine-18 fluorodeoxyglucose positron-emission tomography/computed tomography.
Topics: Aged; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Mandibular Osteotomy; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Surgery, Computer-Assisted; Survival Rate; Tomography, X-Ray Computed | 2012 |
Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose-6-Phosphatase; Hexokinase; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Mouth Floor; Mouth Mucosa; Mouth Neoplasms; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Statistics, Nonparametric; Tongue | 2012 |
PET/CT: Emphasis and current utility in oral cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Preoperative evaluation of patients with squamous cell carcinoma of the oral cavity: fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography and ultrasonography versus histopathology.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2012 |
Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Extracapsular spread and FDG PET/CT correlations in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Floor; Mouth Neoplasms; Neck; Neoplasm Invasiveness; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; ROC Curve; Statistics, Nonparametric; Tomography, X-Ray Computed; Tongue Neoplasms; Young Adult | 2013 |
A hand-held beta imaging probe for FDG.
Topics: Animals; Beta Particles; Diagnostic Imaging; Fluorodeoxyglucose F18; Mouth Neoplasms; Phantoms, Imaging; Rabbits; Time Factors; X-Rays | 2013 |
[Study of oral precancerous lesion and oral cancer by using micro PET/CT].
Topics: Animals; Fluorodeoxyglucose F18; Mouth Neoplasms; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, X-Ray Computed | 2012 |
Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Multivariate Analysis; Neoadjuvant Therapy; Odds Ratio; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Survival Rate; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Male; Monosaccharide Transport Proteins; Mouth Neoplasms; Prognosis; Retrospective Studies; Survival Analysis; Tomography, Emission-Computed | 2003 |
A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2003 |
Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Multiple Primary; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Surveillance of basaloid oral squamous cell carcinoma: the value of [18F]FDG-PET.
Topics: Adult; Aged; Carcinoma, Basosquamous; Carcinoma, Squamous Cell; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Positron-Emission Tomography; Risk Assessment; Sampling Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Diagnostic significance of FDG-PET and argyrophilic nucleolar organizer regions (AgNORs) in oral squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm, Residual; Nucleolus Organizer Region; Prognosis; Radiopharmaceuticals; Silver Staining; Tomography, Emission-Computed | 2004 |
Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Bone invasion in patients with oral cavity cancer: comparison of conventional CT with PET/CT and SPECT/CT.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiographic Image Enhancement; Tomography, Emission-Computed, Single-Photon; Tomography, Spiral Computed | 2005 |
Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Postoperative Care; Prognosis; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Survival Analysis | 2006 |
Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sepsis; Tomography, X-Ray Computed; Upper Extremity; Venous Thrombosis | 2006 |
FDG-PET in the clinically negative neck in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Squamous Cell; Cytodiagnosis; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity | 2006 |
Fluorodeoxyglucose positron emission tomography for the preoperative staging of oral cavity cancers: only one piece of the puzzle.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
The diagnostic role of radioactivity in sentinel nodes in oral and oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2006 |
Focal asymmetric longus colli uptake on FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Mouth Neoplasms; Muscle, Skeletal; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
F-18 FDG PET/CT following dental extraction in a patient with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cervical Vertebrae; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Peritonitis; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Tooth Extraction | 2007 |
Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2008 |
Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Radionuclide Imaging | 1995 |
Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation.
Topics: Contrast Media; Deoxyglucose; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Mouth Neoplasms; Neck; Nose; Orbit; Parotid Neoplasms; Pharynx; Tomography, Emission-Computed; Tongue Neoplasms | 1993 |
Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.
Topics: Aged; Aged, 80 and over; Contrast Media; Deoxyglucose; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Detection of oral dysplasia in animals with fluorine-18-FDG and carbon-11-tyrosine.
Topics: 4-Nitroquinoline-1-oxide; Animals; Carbon Radioisotopes; Carcinogens; Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Mouth Mucosa; Mouth Neoplasms; Radiopharmaceuticals; Rats; Rats, Wistar; Tomography, Emission-Computed; Tyrosine | 1998 |
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 1998 |
[Value of (F18)-2-fluorodeoxyglucose PET scanning in staging mouth cavity carcinoma. Comparative evaluation of PET findings before and after preoperative radiochemotherapy with histological and computerized tomography findings].
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1998 |
Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Use of [F]-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Mandibular Neoplasms; Melanoma; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
[(18F)-2-fluorodeoxyglucose PET. Prospects for secondary prevention of mouth cavity carcinoma].
Topics: Blood Glucose; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Mouth Neoplasms; Neoplasm Recurrence, Local; Predictive Value of Tests; Tomography, Emission-Computed | 2000 |
[Therapy monitoring with 2-(18F)-FDG positron emission tomography after neoadjuvant radiation treatment of mouth carcinoma].
Topics: Adult; Aged; Blood Glucose; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2001 |
Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neoplasms, Second Primary; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Carcinoma, Verrucous; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2001 |
Long-term complete remission of oral cancer after anti-neoplastic chemotherapy as single treatment modality: role of local chemotherapy.
Topics: Aged; Antineoplastic Agents; Cisplatin; Fluorodeoxyglucose F18; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms | 2002 |
Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Prospective Studies; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |